ArticleJournal of translational internal medicine2026

Molecular residual disease-based novel modality of postoperative management for non-small-cell lung cancer (REMODEL): Protocol for a prospective multicenter study.

Xiaoqiu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.